Towards a New Qualitative Screening Assay for Synthetic Cannabinoids Using Metabolomics and Machine Learning.

BACKGROUND: Synthetic cannabinoids (SCs) are steadily emerging on the drug market. To remain competitive in clinical or forensic toxicology, new screening strategies including high-resolution mass spectrometry (HRMS) are required. Machine learning algorithms can detect and learn chemical signatures...

Full description

Bibliographic Details

Published in:	Clinical Chemistry Vol. 68; no. 6; pp. 848 - 856
Main Authors:	Streun, Gabriel L., Steuer, Andrea E., Poetzsch, Sandra N., Ebert, Lars C., Dobay, Akos, Kraemer, Thomas
Format:	Journal Article
Published:	Oxford University Press / USA Jun2022
Online Access:	View this record in EBSCOhost